Trial intelligence / Profile preview

Phase II study of dacomitinib in recurrent glioblastoma with EGFR amplification or EGFRvIII mutation

2011-004671-37Phase 2Completed

Sponsor

Grupo Español de Investigación en Neurooncología

Start

Nov 2011

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1